Middle East & Africa Tumor Ablation Market Size & Outlook
Middle East & Africa tumor ablation market, 2018-2030 (US$M)
Related Markets
MEA tumor ablation market highlights
- The MEA tumor ablation market generated a revenue of USD 126.3 million in 2023.
- The market is expected to grow at a CAGR of 14% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
- Other Ablation Technologies is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Turkey is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 126.3 million |
| Market revenue in 2030 | USD 316.1 million |
| Growth rate | 14% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Other Ablation Technologies |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
Other key industry trends
- In terms of revenue, MEA region accounted for 7.6% of the global tumor ablation market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,085.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Ablation Market Scope
Tumor Ablation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa tumor ablation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.68% in 2023. Horizon Databook has segmented the Middle East & Africa tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East & Africa (MEA) is growing at a moderate rate owing to several factors such as high spending capacity & living standards, presence of well-established medical infrastructure, and increasing number of cases.
In addition, growing government initiatives to increase reimbursement coverage are expected to boost market penetration during the forecast period. Moreover, Gulf Cooperation Council (GCC) is growing rapidly, which indicates the development of technologically advanced medical devices and healthcare infrastructure.
Growing disease burden, increasing healthcare expenditure, and expanding privatization in the healthcare industry are among the factors expected to drive tumor ablation market during the forecast period.
Reasons to subscribe to Middle East & Africa tumor ablation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa tumor ablation market databook
-
Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa tumor ablation market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA tumor ablation market size, by country, 2018-2030 (US$M)
Middle East & Africa Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
